Trevena, Inc. (TRVN)
NASDAQ: TRVN · IEX Real-Time Price · USD
0.238
-0.007 (-3.02%)
At close: Jul 19, 2024, 4:00 PM
0.240
+0.002 (0.84%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Trevena Revenue
Trevena had revenue of $3.14M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $20.00K with 233.33% year-over-year growth. In the year 2023, Trevena had annual revenue of $3.13M.
Revenue (ttm)
$3.14M
Revenue Growth
-826.62%
P/S Ratio
1.39
Revenue / Employee
$136,478
Employees
23
Market Cap
4.37M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.13M | 3.54M | -847.61% |
Dec 31, 2022 | -418.00K | -985.00K | -173.72% |
Dec 31, 2021 | 567.00K | -2.50M | -81.52% |
Dec 31, 2020 | 3.07M | 3.04M | 9,800.00% |
Dec 31, 2019 | 31.00K | -5.70M | -99.46% |
Dec 31, 2018 | 5.73M | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 3.75M | -2.50M | -40.00% |
Dec 31, 2015 | 6.25M | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 134.98K | -672.62K | -83.29% |
Dec 31, 2012 | 807.60K | -1.61M | -66.65% |
Dec 31, 2011 | 2.42M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTRVN News
- 13 days ago - Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing - GlobeNewsWire
- 4 weeks ago - What's Going On With Neurological Disease Focused Trevena On Thursday? - Benzinga
- 4 weeks ago - Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models - GlobeNewsWire
- 2 months ago - Trevena Reports First Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise - GlobeNewsWire
- 7 months ago - Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise - GlobeNewsWire
- 8 months ago - Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting - GlobeNewsWire